For the fifth consecutive week, at least one US IPO gained 30%, as Gigamon (GIMO) climbed nearly 50%. The week's most prominent IPO, Coty (COTY), faltered though, and the third scheduled deal, Aratana Therapeutics (PETX) was delayed. Nine more IPOs,...read more
Gigamon, which provides data traffic management software based appliances, raised $128 million by offering 6.8 million shares (33% insider) at $19, the midpoint of the $18-$20 range. At its offer price, Gigamon commands a fully diluted market value of $612...read more
The following IPOs are expected to price this week: Aratana Therapeutics (PETX), which is developing medications for cats and dogs based on therapies for human, plans to raise $51 million by offering 4.3 million shares at a price range of $11.00 to $13.00. ...read more
US IPO Recap: Coty fades, Gigamon springs and 17 companies file or set terms
For the fifth consecutive week, at least one US IPO gained 30%, as Gigamon (GIMO) climbed nearly 50%. The week's most prominent IPO, Coty (COTY), faltered though, and the third scheduled deal, Aratana Therapeutics (PETX) was delayed. Nine more IPOs,...read more
Gigamon prices IPO at $19, midpoint of the range
Gigamon, which provides data traffic management software based appliances, raised $128 million by offering 6.8 million shares (33% insider) at $19, the midpoint of the $18-$20 range. At its offer price, Gigamon commands a fully diluted market value of $612...read more
3 US IPOs planned for the week of Jun 10
The following IPOs are expected to price this week: Aratana Therapeutics (PETX), which is developing medications for cats and dogs based on therapies for human, plans to raise $51 million by offering 4.3 million shares at a price range of $11.00 to $13.00. ...read more
US IPO Recap: May ends with 30 pricings, two billion-dollar deals set for June
30 IPO...read more